252 related articles for article (PubMed ID: 28061460)
1. L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.
Jo DH; Lee K; Kim JH; Jun HO; Kim Y; Cho YL; Yu YS; Min JK; Kim JH
Oncotarget; 2017 Feb; 8(9):15441-15452. PubMed ID: 28061460
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.
Wang Y; Xin D; Zhou L
Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644
[TBL] [Abstract][Full Text] [Related]
3. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression.
Li C; Zhao J; Sun W
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):9. PubMed ID: 32756923
[TBL] [Abstract][Full Text] [Related]
4. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
5. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor impact on retinoblastoma progression and survival.
Cebulla CM; Jockovich ME; Piña Y; Boutrid H; Alegret A; Kulak A; Hackam AS; Bhattacharya SK; Feuer WJ; Murray TG
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5215-21. PubMed ID: 18614803
[TBL] [Abstract][Full Text] [Related]
7. miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling.
Yang G; Fu Y; Lu X; Wang M; Dong H; Li Q
Int J Oncol; 2019 Jan; 54(1):177-187. PubMed ID: 30387834
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
9. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
[TBL] [Abstract][Full Text] [Related]
10. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
[TBL] [Abstract][Full Text] [Related]
12. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
Souza Filho JP; Martins MC; Caissie AL; Torres VL; Fernandes LH; Erwenne CM; Burnier MN
Clin Exp Ophthalmol; 2005 Jun; 33(3):279-84. PubMed ID: 15932532
[TBL] [Abstract][Full Text] [Related]
13. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma.
Ma H; Nie C; Chen Y; Li J; Xie Y; Tang Z; Gao Y; Ai S; Mao Y; Sun Q; Lu R
Oncol Res; 2021 Sep; 28(7):745-761. PubMed ID: 33573708
[TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
16. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-κB inflammation signals.
Wang F; Liu Y; Bi Z
J Recept Signal Transduct Res; 2017 Feb; 37(1):94-99. PubMed ID: 27133446
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inhibits growth, proliferation, and increases response to chemotherapy in retinoblastoma cells.
Yang Q; Tripathy A; Yu W; Eberhart CG; Asnaghi L
Exp Eye Res; 2017 Sep; 162():48-61. PubMed ID: 28689747
[TBL] [Abstract][Full Text] [Related]
19. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
20. Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells.
Thiyagarajan S; Thirumalai K; Nirmala S; Biswas J; Krishnakumar S
Curr Eye Res; 2009 Oct; 34(10):845-51. PubMed ID: 19895312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]